Filana Therapeutics, Inc. Payments of Stock Issuance Costs
Filana Therapeutics, Inc. (FLNA) reported Payments of Stock Issuance Costs of $51.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-05-07
- Filana Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $51.00K.
- Filana Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $0.00.
- Filana Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2019-12-31 was $0.00.
- Filana Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2019-09-30 was $0.00.
- Filana Therapeutics, Inc. payments of stock issuance costs for fiscal 2019 was $60.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-03-31 | $51.00K 10-Q · filed 2026-05-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $0.00 derived: sum of 2 quarters · filed 2021-03-23 | $0.00 derived: sum of 3 quarters · filed 2021-03-23 | $60.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $60.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $60.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $60.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |